Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing’s Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

TYPE OF SARCOMA: Recurrent Ewing’s Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma
DRUG: Gemcitabine and Docetaxel
ACCRUAL STATUS: Completed

OVERALL STUDY PRINCIPAL INVESTIGATORS:
Shreyas Patel, MD
MD Anderson Cancer Center

Elizabeth Fox, MD
St. Jude Children’s Research Hospital

CLINICALTRIALS.GOV IDENTIFIER: NCT00073983

FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV

To learn more about this study or to contact the study research staff: